Sofia Pazmiño

1.4k total citations
57 papers, 354 citations indexed

About

Sofia Pazmiño is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Sofia Pazmiño has authored 57 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Rheumatology, 20 papers in Hematology and 10 papers in Immunology. Recurrent topics in Sofia Pazmiño's work include Rheumatoid Arthritis Research and Therapies (40 papers), Autoimmune and Inflammatory Disorders Research (20 papers) and Systemic Lupus Erythematosus Research (11 papers). Sofia Pazmiño is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (40 papers), Autoimmune and Inflammatory Disorders Research (20 papers) and Systemic Lupus Erythematosus Research (11 papers). Sofia Pazmiño collaborates with scholars based in Belgium, Netherlands and United States. Sofia Pazmiño's co-authors include Patrick Verschueren, René Westhovens, Diederik De Cock, Delphine Bertrand, Veerle Stouten, Johan Joly, Kristien Van der Elst, Rik Lories, Kurt de Vlam and Annelies Boonen and has published in prestigious journals such as Advanced Materials, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

In The Last Decade

Sofia Pazmiño

45 papers receiving 352 citations

Peers

Countries citing papers authored by Sofia Pazmiño

Since Specialization

Citations

This map shows the geographic impact of Sofia Pazmiño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Pazmiño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Pazmiño more than expected).

Fields of papers citing papers by Sofia Pazmiño

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Pazmiño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Pazmiño. The network helps show where Sofia Pazmiño may publish in the future.

Co-authorship network of co-authors of Sofia Pazmiño

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Pazmiño. A scholar is included among the top collaborators of Sofia Pazmiño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Pazmiño. Sofia Pazmiño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naïve early psoriatic arthritis 2025 ·RMD Open ·(unknown), Margot Van Mechelen, Sofia Pazmiño, (unknown), Barbara Neerinckx, Patrick Verschueren, Rik Lories, Kurt de Vlam	0
2	Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT ‐ ONE 2024 ·Diabetes Obesity and Metabolism ·Nele Steenackers, Thomas Sparsø, Sara Charleer, Christophe De Block, Diederik De Cock, (unknown), Chantal Mathieu, Frank Nobels, Sofia Pazmiño, Jonathan Rosen, Carmen Hurtado del Pozo, Pieter Gillard, Bart Van der Schueren	0
3	A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial 2024 ·Lara D. Veeken ·(unknown), (unknown), Delphine Bertrand, Sofia Pazmiño, (unknown), Johan Joly, (unknown), René Westhovens, Patrick Verschueren	1
4	Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study 2024 ·EClinicalMedicine ·Ebaa Al‐Ozairi, Nele Steenackers, Sofia Pazmiño, (unknown), (unknown), Paloma Almeda‐Valdés, Neftalí Eduardo Antonio-Villa, (unknown), Raquel N. Faradji, (unknown), Mohammad Irshad, J. Craig Longenecker, Jonathan Rosen, Carmen Hurtado del Pozo, Thomas Sparsø, Astrid Lavens, Chantal Mathieu, Bart Van der Schueren, Carel W. le Roux	5
5	OP0287-HPR ONE-IN-THREE PATIENTS WITH RHEUMATOID ARTHRITIS REPORT CLINICALLY IMPORTANT WORSENING ON THE RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) BETWEEN CLINIC VISITS: ENGAGEMENT AND PATIENT-REPORTED OUTCOME RESULTS FROM A SMARTPHONE APP FOR PATIENT EDUCATION AND REMOTE MONITORING 2024 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), Sofia Pazmiño, (unknown), (unknown), (unknown)	0
6	AB0525 EARLY RESPONDERS TO REMISSION-INDUCTION TREATMENT WITH METHOTREXATE AND BRIDGING GLUCOCORTICOIDS REPORT LOWER RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) OVER 2 YEARS: SECONDARY ANALYSIS OF THE CARERA2020 TRIAL 2024 ·Annals of the Rheumatic Diseases ·(unknown), Delphine Bertrand, (unknown), (unknown), Sofia Pazmiño, (unknown), (unknown)	0
7	Comorbidities in Early Psoriatic Arthritis: Data From the Metabolic Disturbances in Psoriatic Arthritis Cohort Study 2023 ·Arthritis Care & Research ·(unknown), Sofia Pazmiño, Barbara Neerinckx, Rik Lories, Kurt de Vlam	13
8	A retrospective study of people with familial hypercholesterolaemia in a Belgian lipid clinic 2023 ·Acta cardiologica. Supplementum ·(unknown), Diederik De Cock, Sofia Pazmiño, Roman Vangoitsenhoven, Bart Van der Schueren, Ann Mertens	0
9	Inhibition of KDM7A/B histone demethylases restores H3K79 methylation and protects against osteoarthritis 2023 ·Annals of the Rheumatic Diseases ·(unknown), C. Cherifi, F.M. Cornelis, (unknown), (unknown), Sofia Pazmiño, Rodrigo Coutinho de Almeida, Ingrid Meulenbelt, Rik Lories, Silvia Monteagudo	28
10	POS0327 SPEED OF RESPONSE MATTERS: POST-HOC ANALYSIS OF PATIENTS WITH EARLY SERONEGATIVE RHEUMATOID ARTHRITIS INCLUDED IN THE CARERA TRIAL 2023 ·Annals of the Rheumatic Diseases ·Sofia Pazmiño, René Westhovens, Veerle Stouten, Delphine Bertrand, (unknown), Johan Joly, (unknown), (unknown), Patrick Verschueren	0
11	Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA) 2023 ·Trials ·(unknown), (unknown), (unknown), Sofia Pazmiño, Johan Joly, Delphine Bertrand, (unknown), René Westhovens, Patrick Verschueren	3
12	New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis 2022 ·Lara D. Veeken ·Sofia Pazmiño, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, (unknown), Delphine Bertrand, René Westhovens, Patrick Verschueren	8
13	Hypoxia and Wnt signaling inversely regulate expression of chondroprotective molecule ANP32A in articular cartilage 2022 ·Osteoarthritis and Cartilage ·(unknown), (unknown), F.M. Cornelis, (unknown), An Sermon, Sofia Pazmiño, Silvia Monteagudo, Rik Lories	6
14	POS1073 INCREASED NUMBER OF COMORBIDITIES AND CARDIOVASCULAR RISK FACTORS IN EARLY PSORIATIC ARTHRITIS PATIENTS SUGGESTS AN INTRINSIC DISEASE IMPACT. 2022 ·Annals of the Rheumatic Diseases ·(unknown), Sofia Pazmiño, (unknown), Rik Lories	1
15	Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity 2022 ·Joint Bone Spine ·(unknown), Sofia Pazmiño, Delphine Bertrand, René Westhovens, Patrick Verschueren	13
16	Psychological stress in rheumatoid arthritis: a systematic scoping review 2022 ·Seminars in Arthritis and Rheumatism ·Diederik De Cock, (unknown), (unknown), (unknown), Delphine Bertrand, Sofia Pazmiño, René Westhovens, Patrick Verschueren	11
17	POS1434 WHICH PROGNOSTIC FACTORS MIGHT PREDICT THE NEED FOR TREATMENT ADAPTATION IN EARLY RHEUMATOID ARTHRITIS? A COMPARISON OF MACHINE LEARNING, SURVIVAL ANALYSIS AND REGRESSION METHODS 2021 ·Annals of the Rheumatic Diseases ·(unknown), Tim Verdonck, Sofia Pazmiño, Veerle Stouten, Delphine Bertrand, (unknown), René Westhovens, Patrick Verschueren, Diederik De Cock	1
18	Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial 2021 ·Annals of the Rheumatic Diseases ·Veerle Stouten, René Westhovens, Sofia Pazmiño, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren	21
19	Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT 2020 ·Clinical Rheumatology ·Veerle Stouten, (unknown), René Westhovens, Diederik De Cock, (unknown), Sofia Pazmiño, Kristien Van der Elst, Johan Joly, Patrick Verschueren	1
20	OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial 2017 ·Annals of the Rheumatic Diseases ·Veerle Stouten, Johan Joly, Diederik De Cock, Sofia Pazmiño, Kristien Van der Elst, René Westhovens, Patrick Verschueren	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact